Multidimensional barriers and facilitators to early phase clinical trial (EPCT) participation among diverse patients with advanced solid tumors.
Barriers to EPCT participation among a group of minoritized trial participants and caregivers were driven by a combination of limited awareness, language barriers, logistical intensity, fear of uncertainty, and historical distrust.